Literature DB >> 22413983

Stenting the patent ductus arteriosus in duct-dependent pulmonary circulation: techniques, complications and follow-up issues.

Mazeni Alwi1.   

Abstract

Maintaining ductal patency in duct-dependent congenital heart lesions by implantation of coronary stents is an alternative to systemic pulmonary shunt in selected cases and lesions with suitable anatomy. This article focuses on the procedure as the initial palliation in duct-dependent pulmonary circulation, its associated pitfalls and complications. A good understanding of the diverse duct morphology is paramount prior to stenting of the ductus. Long tortuous duct, insufficiently constricted ductus at the pulmonary end and ductus with associated branch pulmonary artery stenosis at the site of insertion are not suitable for stenting. Durability of palliation is generally inferior to a surgical shunt and this may dictate earlier definitive surgical repair. Acceleration of branch pulmonary artery stenosis in certain ductal morphology limits its general applicability. Bioabsorbable and biodegradable stents may offer some solution to this problem.

Entities:  

Mesh:

Year:  2012        PMID: 22413983     DOI: 10.2217/fca.12.4

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  3 in total

1.  Feasibility, safety, and efficacy of iron bioresorbable scaffold in neonates with duct-dependent pulmonary circulation.

Authors:  Marhisham Che Mood; Khalil Ahmad Niazy; Mazeni Alwi; Hasri Samion; Koh Ghee Tiong; Sivakumar Sivalingam; Deyuan Zhang
Journal:  Ann Pediatr Cardiol       Date:  2022-08-19

2.  Bilateral Ductal Stenting for Discontinuity of the Pulmonary Artery via the Femoral and Carotid Arteries in an Infant.

Authors:  Osman Baspinar; Derya Aydin Sahin
Journal:  Case Rep Cardiol       Date:  2015-03-29

3.  Arterial duct stent versus surgical shunt for patients with duct-dependent pulmonary circulation: a meta-analysis.

Authors:  Dongxu Li; Xu Zhou; Mengsi Li
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.